Skip to main content
Premium Trial:

Request an Annual Quote

ACMG Foundation: Brynn Levy, David Tilstra

Brynn Levy and David Tilstra have been elected to the board of directors of the ACMG Foundation for Genetic and Genomic Medicine, a nonprofit organization that facilitates the integration of genetics and genomics into medical practice.

Levy is a professor in the Department of Pathology & Cell Biology at Columbia University Irving Medical Center and co-director of the department's division of personalized genomic medicine. In addition, he is the medical director of the clinical cytogenetics laboratory of New York Presbyterian Hospital.

Tilstra is president emeritus of CentraCare Clinic. Until the end of 2018, he was the clinic's president, and before that, its medical director. Tilstra holds an MBA from the University of Colorado Denver, an MD from the University of Iowa College of Medicine, and an undergraduate degree in chemistry from Northwestern College of Orange City.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.